Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.
| Current Price | ₹8.11 |
|---|---|
| Market Cap | ₹8 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > 0 |
| P/E Ratio | -98.8 |
| Return on Equity | -9.12% |
| 52-Week Range | ₹6.86 – ₹13.47 |
| Beta (1Y) | 0.15 |
Hindustan Bio Sciences Ltd is trading at ₹8.11, with a market capitalisation of ₹8 Cr.
Hindustan Bio Sciences Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > 0).
Hindustan Bio Sciences Ltd has a P/E of -98.8 and a return on equity of -9.12%.